906095-21-4

Upstream product

• 90-02-8 salicylaldehyde 
• 548-93-6 3-hydroxyanthranilic acid 
• 5896-17-3 2-(phenylmethoxy)benzaldehyde 
• 186501-24-6 methyl 2-(2-(benzyloxy)phenyl)benzo[d]oxazole-4-carboxylate 
• 186501-25-7 2-(2-(benzyloxy)phenyl)benzo[d]oxazole-4-carboxylic acid 
• 17672-21-8 2-amino-3-hydroxy-benzoic acid methyl ester 
• 186501-22-4 2-(2-methoxyphenyl)benzo[d]oxazole-4-carboxylic acid 

Downstream Products

• 151271-53-3 2'-(2-hydroxyphenyl)-2,4'-bibenzoxazole-4-carboxylic acid methyl ester 

Relevant academic research and scientific papers

Synthetic method of anticancer drug UK-1

The invention discloses a synthetic method of an anticancer drug UK-1. The method comprises the following steps: mixing a methyl 2-amino-3-hydroxybenzoate compound, an aldehyde and a molecular sieve to generate a mixture; performing heating reflux on the

Synthesis of caboxamycin and its derivatives using eco-friendly oxidation

The reaction of 3-hydroxyanthranilic acid or methyl 3-hydroxyanthranilate with O-benzylsalicylaldehyde in xylenes gave benzoxazole derivatives, which lead to a novel benzoxazole antibiotic, caboxamycin via debenzylation or demethylation in good yield, in

Benzoxazole carboxamides for treating CINV and IBS-D

Compounds of formulae I and II: are disclosed as 5-HT3 inhibitors. Those compounds that exhibit central activity are useful in treating CINV; those that inhibit peripheral receptors are useful to treat IBS-D.